-+ 0.00%
-+ 0.00%
-+ 0.00%

The Zhitong Finance App learned that J.P. Morgan Chase released a research report saying that the stock price of Cinda Biotech (01801.HK) fell by about 7% on Monday. The bank believes this may be related to the National Medicare Drug Catalogue (NRDL) published over the weekend. The stock is still rated as “overweight.”

Zhitongcaijing·12/10/2025 05:57:03
Listen to the news
The Zhitong Finance App learned that J.P. Morgan Chase released a research report saying that the stock price of Cinda Biotech (01801.HK) fell by about 7% on Monday. The bank believes this may be related to the National Medicare Drug Catalogue (NRDL) published over the weekend. The stock is still rated as “overweight.”